Menu
Medical Condition
Pediatrics & Neonatology
Pediatrics & Neonatology ICD-10: M91.1

Perthes Disease (LCPD)

Standardized diagnosis for Perthes Disease (LCPD).

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

EN: Patient presents with a chronic, insidious onset of intermittent hip/knee pain and a persistent antalgic gait. No history of acute trauma. Symptoms exacerbated by physical activity and relieved by rest. No systemic signs of infection (fever, chills). AR: يعاني المريض من ألم مزمن وتدريجي في الورك أو الركبة مع عرج مستمر. لا يوجد تاريخ لصدمة حادة. تتفاقم الأعراض مع النشاط البدني وتتحسن بالراحة. لا توجد علامات جهازية للعدوى (حمى أو قشعريرة).

General Examination

EN: Physical exam reveals limited range of motion in the affected hip, particularly internal rotation and abduction. Positive Trendelenburg sign may be present. Muscle atrophy of the thigh may be noted. Neurovascular status is intact distally. AR: يكشف الفحص البدني عن محدودية في نطاق حركة الورك المصاب، خاصة في الدوران الداخلي والإبعاد. قد تظهر علامة ترينديلينبورغ إيجابية. قد يلاحظ وجود ضمور في عضلات الفخذ. الحالة العصبية الوعائية سليمة في الأطراف.

Treatment Protocol

EN: Management plan includes activity modification, physical therapy to maintain joint range of motion, and non-steroidal anti-inflammatory drugs (NSAIDs) for pain management. Orthopedic referral for containment therapy (bracing or surgical osteotomy) based on Waldenström stage and Herring classification. AR: تشمل خطة العلاج تعديل الأنشطة، والعلاج الطبيعي للحفاظ على نطاق حركة المفصل، ومضادات الالتهاب غير الستيرويدية (NSAIDs) لتسكين الألم. تحويل المريض إلى جراحة العظام لتقييم الحاجة إلى علاج الاحتواء (باستخدام دعامات أو جراحة قطع العظم) بناءً على مرحلة "والدنستروم" وتصنيف "هيرينغ".

Patient Education

EN: Perthes disease involves temporary loss of blood supply to the femoral head. Treatment focuses on protecting the hip joint while the bone heals and reshapes. Strict adherence to activity restrictions is essential to prevent deformity. Follow-up imaging is required to monitor progression. AR: مرض بيرثيس يتضمن فقدانًا مؤقتًا لإمدادات الدم إلى رأس عظمة الفخذ. يركز العلاج على حماية مفصل الورك أثناء التئام العظم وإعادة تشكيله. الالتزام الصارم بقيود النشاط ضروري لمنع التشوه. يلزم إجراء تصوير متابعة لمراقبة تطور الحالة.

Systemic & Specialized Examinations

Neurological

EN: Intact globally. AR: سليم.

Orthopedic & Trauma Assessments

Mechanism of Injury

EN: Developmental/Congenital etiology. No acute trauma. AR: سبب تطوري/خلقي. لا توجد صدمة حادة.

Gait & Posture

EN: Limping, toe-walking, or waddling gait observed (or pre-ambulatory infant). AR: يلاحظ عرج، مشي على الأصابع، أو مشية البطة (أو رضيع قبل مرحلة المشي).

Local Examination

EN: Asymmetric skin folds (gluteal/thigh). Apparent leg length discrepancy (Galeazzi sign positive). AR: طيات جلدية غير متماثلة (أرداف/فخذ). تباين واضح في طول الساقين (علامة غاليازي إيجابية).

Special Tests

EN: Barlow Maneuver: Provocative test reveals palpable clunk. Ortolani Maneuver: Gentle abduction reduces hip with clunk. AR: مناورة بارلو: تظهر طقطقة خلع. مناورة أورتولاني: ترد الورك بطقطقة.

Motor Power

EN: Moves all extremities equally. AR: يحرك جميع الأطراف بالتساوي.

Sensory Profile

EN: Withdraws to light stimulus. AR: يسحب الطرف استجابة للمس.

Reflexes

EN: 2+ symmetric. No clonus. AR: 2+ متماثلة.

Peripheral Pulses

EN: Strong and symmetric. AR: قوية ومتماثلة.

Comprehensive Clinical Guide: Legg-Calvé-Perthes Disease (LCPD)

Legg-Calvé-Perthes Disease (LCPD), commonly referred to as Perthes disease, represents one of the most enigmatic and clinically significant conditions in pediatric orthopedics. It is defined as an idiopathic osteonecrosis of the capital femoral epiphysis (CFE) in children. Characterized by a self-limiting interruption of the blood supply to the femoral head, the condition leads to bone death, subsequent resorption, and eventual reossification.

Understanding LCPD requires a multidisciplinary perspective, bridging pediatric radiology, orthopedic surgery, and physical rehabilitation. While the condition is typically self-limiting, the long-term structural integrity of the hip joint depends heavily on the child's age at onset, the extent of epiphyseal involvement, and the efficacy of containment strategies.


1. Deep-Dive: Etiology and Pathophysiology

The exact etiology of LCPD remains multifactorial and arguably idiopathic. However, the prevailing clinical consensus identifies a vascular compromise—ischemia—as the primary trigger.

The Mechanism of Ischemia

The blood supply to the developing femoral head is tenuous. In the pediatric population, the medial circumflex femoral artery is the primary source of perfusion. Research suggests that repeated episodes of transient ischemia, potentially triggered by hypercoagulability, venous outflow obstruction, or systemic coagulation abnormalities (such as Factor V Leiden mutations or Protein C/S deficiencies), lead to osteonecrosis.

The Pathophysiological Stages

The natural history of LCPD follows a predictable, albeit lengthy, cycle of biological remodeling:

Stage Pathological Description
Stage 1: Necrosis Cessation of blood flow; death of osteocytes; growth of the epiphysis stops.
Stage 2: Fragmentation Revascularization begins; osteoclasts resorb dead bone; epiphysis becomes structurally weak.
Stage 3: Reossification New bone formation occurs; the femoral head begins to take a new shape.
Stage 4: Remodeling The femoral head reaches its final shape; joint congruency is established.

2. Clinical Presentation and Diagnostic Criteria

LCPD typically presents in children between the ages of 4 and 10, with a male-to-female ratio of approximately 4:1.

Standard Presentation

  • Antalgic Gait: A classic limp, often exacerbated by activity and relieved by rest.
  • Pain: Often referred to the knee or medial thigh rather than the hip, which can lead to diagnostic delays.
  • Limited Range of Motion (ROM): Specifically, abduction and internal rotation are restricted due to synovitis and muscle guarding.
  • Muscle Atrophy: Disuse atrophy of the thigh muscles is frequently observed on the affected side.

Clinical Staging: The Waldenström Classification

The progression of LCPD is clinically tracked using the Waldenström classification, which categorizes the disease into the four stages mentioned in the pathophysiology section above.

Radiographic Staging: The Herring (Lateral Pillar) Classification

The Herring classification is the most critical prognostic tool, based on the integrity of the lateral pillar of the femoral head on an AP radiograph:
* Group A: No involvement of the lateral pillar.
* Group B: Less than 50% height loss of the lateral pillar.
* Group C: More than 50% height loss of the lateral pillar.


3. Diagnostic Modalities

Diagnosis requires a combination of clinical suspicion and high-quality imaging.

  1. Radiography: The gold standard. Initial signs may include a widened joint space (medial joint space widening), followed by the "crescent sign" (a subchondral fracture line) and eventual fragmentation.
  2. MRI: The most sensitive tool for early detection. MRI can identify ischemia before radiographic changes become apparent. It is essential for mapping the extent of necrosis.
  3. Bone Scintigraphy: Historically used to assess blood flow, though largely superseded by MRI in modern practice.

Differential Diagnosis

To ensure an accurate LCPD diagnosis, clinicians must rule out:
* Transient Synovitis: Usually resolves within 1–2 weeks.
* Septic Arthritis: An orthopedic emergency requiring urgent aspiration.
* Slipped Capital Femoral Epiphysis (SCFE): Typically occurs in older, often obese adolescents.
* Multiple Epiphyseal Dysplasia (MED): Often bilateral and systemic.


4. Risks, Complications, and Management

The primary goal of LCPD management is to prevent "hinge abduction" and ensure that the femoral head remains contained within the acetabulum during the remodeling process.

Management Strategies

  • Observation: Indicated for younger children (under age 6) with minimal involvement.
  • Physical Therapy: Focuses on maintaining hip abduction and preventing contractures.
  • Containment Surgery (Osteotomy): For children over age 8 or those with "at-risk" signs, femoral or pelvic osteotomies may be performed to keep the femoral head within the acetabular socket.
  • Bisphosphonates: Emerging, though controversial, research suggests these may help reduce bone resorption in severe cases.

Contraindications

  • Aggressive Force-Based Physical Therapy: Forcing range of motion during the fragmentation phase can lead to irreversible deformity.
  • Long-term Non-Weight Bearing: Modern evidence suggests that strict bed rest is rarely indicated and may lead to psychological and developmental harm.

5. Frequently Asked Questions (FAQ)

Q1: Is Perthes disease hereditary?
A: While there is no direct genetic inheritance pattern, a family history of hip problems or coagulation disorders is occasionally noted. It is generally considered a sporadic condition.

Q2: Can my child play sports with Perthes?
A: High-impact sports are typically restricted. Low-impact activities like swimming or cycling are often encouraged to maintain joint mobility without mechanical stress.

Q3: How long does the healing process take?
A: The entire cycle, from initial necrosis to final remodeling, typically spans 2 to 4 years.

Q4: Will my child have a limp for the rest of their life?
A: If the femoral head heals in a spherical shape, most children return to full, normal function. Deformity (coxa magna) may lead to an altered gait.

Q5: Is surgery always required?
A: No. Surgery is reserved for patients at high risk of poor outcomes, typically based on age and the Herring classification.

Q6: What is the "Crescent Sign"?
A: It is a radiolucent line seen on an X-ray representing a subchondral fracture, indicating the necrotic bone is beginning to collapse.

Q7: Can Perthes affect both hips?
A: Yes, though it is bilateral in only about 10–15% of cases. When it is bilateral, it rarely occurs simultaneously.

Q8: What is the biggest risk of untreated Perthes?
A: The primary risk is permanent deformity of the femoral head, leading to early-onset osteoarthritis in early adulthood.

Q9: Does diet or nutrition play a role?
A: There is no evidence that diet causes Perthes. However, maintaining general bone health through adequate Vitamin D and Calcium is standard pediatric advice.

Q10: What is "Hinge Abduction"?
A: This occurs when the flattened femoral head hits the lateral edge of the acetabulum during abduction, causing pain and mechanical blockage. It is a sign that surgical intervention may be necessary.


6. Long-Term Prognosis and Clinical Outlook

The prognosis for LCPD is heavily dependent on the age at onset. Children under the age of 6 generally have an excellent prognosis, as they have significant remodeling potential remaining in the hip socket. Patients who develop the disease after age 8, or those with significant lateral pillar collapse, face a higher risk of long-term sequelae.

Summary Table: Prognostic Outlook

Age at Onset Prognostic Outlook
Under 6 years Excellent; high potential for natural remodeling.
6 to 8 years Guarded; depends on the extent of containment.
Over 8 years Poor; high risk of premature hip replacement in adulthood.

Conclusion for Practitioners

Management of Perthes disease requires patience and a "wait-and-watch" approach balanced with vigilant monitoring. The orthopedic specialist must prioritize the maintenance of joint congruency. While the condition is physically and emotionally taxing for the patient and family, modern surgical and conservative techniques have significantly improved the long-term functional outcomes for the vast majority of pediatric patients.

Continued research into the role of thrombophilia and early MRI biomarkers remains the frontier of LCPD management, potentially offering future opportunities for earlier, more targeted therapeutic interventions that could shorten the duration of the disease process.


Disclaimer: This guide is provided for educational purposes for healthcare professionals and is not a substitute for clinical judgment. Always refer to current institutional protocols and the latest peer-reviewed orthopedic literature when treating pediatric patients.

Treatment & Management Options

Share this guide: